Literature DB >> 3524725

The AMDP-system in clinical psychopharmacology.

D Bobon, B Woggon.   

Abstract

The AMDP-System has been developed in Europe by the Association for Methodology and Documentation in Psychiatry the standardised documentation of psychiatric files and for the measurement of change in drug trials. It is increasingly used in the French-speaking and German-speaking countries by clinical psychopharmacologists for teaching classical German psychopathological concepts to students and for the multicentre and multifactorial evaluation of drug changes. The AMDP-System consists of three anamnestic forms and of two comprehensive rating scales on present psychopathology (100 items + write-in items) and somatic complaints (40 items + write-in items).

Entities:  

Mesh:

Year:  1986        PMID: 3524725     DOI: 10.1192/bjp.148.4.467

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  4 in total

1.  Delusional disorders--are they simply paranoid schizophrenia?

Authors:  Andreas Marneros; Frank Pillmann; Tobias Wustmann
Journal:  Schizophr Bull       Date:  2010-11-15       Impact factor: 9.306

Review 2.  Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

3.  Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study.

Authors:  Istvan Bitter; Tamás Treuer; Nesrin Dilbaz; Igor Oyffe; Eda M Ciorabai; Severiano L Gonzalez; Sandra Ruschel; Jolanta Salburg; Yulia Dyachkova
Journal:  World J Biol Psychiatry       Date:  2010-10       Impact factor: 4.132

4.  Weed or wheel! FMRI, behavioural, and toxicological investigations of how cannabis smoking affects skills necessary for driving.

Authors:  Giovanni Battistella; Eleonora Fornari; Aurélien Thomas; Jean-Frédéric Mall; Haithem Chtioui; Monique Appenzeller; Jean-Marie Annoni; Bernard Favrat; Philippe Maeder; Christian Giroud
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.